Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 2;14(3):577-585.
doi: 10.1159/000510215. eCollection 2020 Sep-Dec.

Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma

Affiliations
Case Reports

Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma

Joris T Hepkema et al. Case Rep Gastroenterol. .

Abstract

Hepatocellular adenomas (HCA) are rare benign tumors of the liver, occurring predominantly in females using oral contraceptives. Our case describes a 66-year-old woman presenting with a palpable mass in her upper abdomen. Contrast-enhanced computed tomography and magnetic resonance imaging showed a large exophytic mass protruding from the caudal border of liver segments IV and V, without visible metastases. Laparoscopic resection of the tumor and gallbladder was performed. Histopathological examination showed a hepatocellular carcinoma with areas of HNF1a-HCA (H-HCA). This case shows that malignant transformation is possible in H-HCA. We present our preoperative decision-making process, as well as the role of imaging techniques in this rare case.

Keywords: Hepatocellular adenoma; Hepatocellular carcinoma; Hepatocyte nuclear factor 1-alpha; Imaging; Laparoscopy; Surgical resection.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
CT and MRI of the exophytic liver tumor. a Coronal contrast-enhanced CT image of the abdomen at the portal venous phase showing the large exophytic mass originating from the caudal border of liver segments 4B and 5 with a heterogeneous enhancement pattern. b Axial fat-suppressed T2-weighted MR image showing the large tumor with heterogeneous hyperintense signal intensity. c–e Axial fat-suppressed T1-weighted MR images at the arterial (c), portal venous (d), and delayed phase (e), showing slight heterogeneous, predominantly peripheral arterial enhancement, with increasing enhancement at the portal venous and delayed phases. No significant drop of signal intensity was present at the opposed-phase T1-weighted images (not shown).
Fig. 2
Fig. 2
Macroscopic aspect. Fresh resection specimen whole (a) and sliced (b). Almost the whole specimen was lesional and consisted of a multinodular tumor with partial myxoid/necrotic aspect and partial capsule formation. The different nodules were microscopically not clearly demarcated in HCC or adenoma, with an intimate mixture of the two components. Microscopic aspect. c Both components present, with the HCC component on top of the image and the adenomatous component at the bottom. The HCC is characterized by trabecular and pseudoglandular structures, while the adenomatous component consists of atrophic hepatocytes with some sinusoidal dilatation while unpaired arteries are present and portal tracts are absent (HE. ×10). d The same area in the reticulin stain. Note the disrupted reticulin framework and the thickened pseudoglandular structures in the HCC component, while the reticulin framework is preserved in the adenoma component.
Fig. 3
Fig. 3
Microscopic aspect with staining. Images were acquired through digital pathology. Objective is shown. a CD34 control staining at ×5. b CD34 staining at ×5. c LFABP control staining at ×5. d LFABP staining of the HCC at ×10. e LFABP staining of the border between lesional and non-lesional tissue at ×1. f Amyloid-AA staining with control at ×1. g CRP staining at ×5. h CRP control staining at ×10. i Beta-catenin control staining at ×10. j Beta-catenin staining at ×10. k Glutamine staining at ×5. l Glutamine control staining at ×5.

References

    1. Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular Adenomas: morphology and Genomics. Gastroenterol Clin North Am. 2017 Jun;46((2)):253–72. - PubMed
    1. Haring MP, Gouw AS, de Haas RJ, Cuperus FJ, de Jong KP, de Meijer VE. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study. Liver Int. 2019 May;39((5)):905–13. - PMC - PubMed
    1. Perret AG, Mosnier JF, Porcheron J, Cuilleron M, Berthoux P, Boucheron S, et al. Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman. J Hepatol. 1996 Dec;25((6)):976–9. - PubMed
    1. Stoot J, Coelen R, De Jong M, Dejong C. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB. 12((8)):509–522. - PMC - PubMed
    1. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009 Nov;137((5)):1698–705. - PubMed

Publication types